151 related articles for article (PubMed ID: 10531751)
1. [Cytogenetic findings in ductal carcinoma of the breast].
Rojas-Atencio A; González L; Urdaneta K; Soto-Alvarez M; Prieto-Carrasquero M; Fulcado W; Quintero M; Boscán A; Alvarez Nava F
Invest Clin; 1999 Sep; 40(3):179-89. PubMed ID: 10531751
[TBL] [Abstract][Full Text] [Related]
2. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer.
Teixeira MR; Pandis N; Bardi G; Andersen JA; Heim S
Cancer Res; 1996 Feb; 56(4):855-9. PubMed ID: 8631024
[TBL] [Abstract][Full Text] [Related]
3. Unusual clonal chromosomal evolution in a breast carcinoma and its lymph node metastasis in a patient with Down syndrome.
Bernardino J; Gerbault-Seureau M; Sastre X; Dutrillaux B
Genes Chromosomes Cancer; 1997 Jul; 19(3):195-9. PubMed ID: 9219002
[TBL] [Abstract][Full Text] [Related]
4. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
5. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics of agnogenic myeloid metaplasia: a study of 61 patients.
Djordjevic V; Dencic-Fekete M; Jovanovic J; Bizic S; Jankovic G; Bogdanovic A; Cemerikic-Martinovic V; Gotic M
Cancer Genet Cytogenet; 2007 Feb; 173(1):57-62. PubMed ID: 17284371
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a new cytogenetic subtype of ductal breast carcinomas.
Molist R; Remvikos Y; Dutrillaux B; Muleris M
Oncogene; 2004 Aug; 23(35):5986-93. PubMed ID: 15208688
[TBL] [Abstract][Full Text] [Related]
8. Distinct karyotypes in three breast cancer cell lines --21PTCi, 21NTCi, and 21MT-1 --derived from the same patient and representing different stages of tumor progression.
Xu J; Souter LH; Chambers AF; Rodenhiser DI; Tuck AB
Cancer Genet Cytogenet; 2008 Oct; 186(1):33-40. PubMed ID: 18786440
[TBL] [Abstract][Full Text] [Related]
9. Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer.
Flagiello D; Gerbault-Seureau M; Sastre-Garau X; Padoy E; Vielh P; Dutrillaux B
Genes Chromosomes Cancer; 1998 Dec; 23(4):300-6. PubMed ID: 9824202
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic analysis of sinonasal carcinomas.
Gil Z; Orr-Urtreger A; Voskoboinik N; Trejo-Leider L; Spektor S; Shomrat R; Fliss DM
Otolaryngol Head Neck Surg; 2006 Apr; 134(4):654-60. PubMed ID: 16564392
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic analysis of breast cancer: a combined multicolor fluorescence in situ hybridization and G-banding study of uncultured tumor cells.
Ferti AD; Stamouli MJ; Panani AD; Raptis SA; Young BD
Cancer Genet Cytogenet; 2004 Feb; 149(1):28-37. PubMed ID: 15104280
[TBL] [Abstract][Full Text] [Related]
12. [Cytogenetic analysis on 1058 cases of acute nonlymphocytic leukemia].
Xue Y; Guo Y; Wu Y; Pan J; Li J; Lu D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):247-50. PubMed ID: 11484158
[TBL] [Abstract][Full Text] [Related]
13. Banding analysis of three primary cancers.
Kovács G
Acta Cytol; 1978; 22(6):538-41. PubMed ID: 282753
[TBL] [Abstract][Full Text] [Related]
14. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
[TBL] [Abstract][Full Text] [Related]
15. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
16. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
17. A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast.
Tibiletti MG; Sessa F; Bernasconi B; Cerutti R; Broggi B; Furlan D; Acquati F; Bianchi M; Russo A; Capella C; Taramelli R
Clin Cancer Res; 2000 Apr; 6(4):1422-31. PubMed ID: 10778973
[TBL] [Abstract][Full Text] [Related]
18. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
Gong Y; Booser DJ; Sneige N
Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
[TBL] [Abstract][Full Text] [Related]
19. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution.
Buerger H; Mommers EC; Littmann R; Simon R; Diallo R; Poremba C; Dockhorn-Dworniczak B; van Diest PJ; Boecker W
J Pathol; 2001 Jun; 194(2):165-70. PubMed ID: 11400144
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
